Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers

NCT01079286 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Cancer
Cancer

Interventions

DRUG: Nelfinavir and temsirolimus

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)